Remilk

EN Texto em inglês Ainda não há artigo no teu idioma: trecho em inglês.

Remilk is a multi-national Israeli company that specializes in the production of cultured milk and dairy products. The company was founded in 2019 by CEO Aviv Wolff and CTO Ori Cohavi. It has developed a method of yeast-based fermentation to produce milk proteins with an identical chemical compound to that of milk traditionally produced by cows. Remilk was founded in 2019 by Aviv Wolff and Ori Cohavi. In December 2020, the company completed a Series A funding round of $11 million. Among its initial investors were Hochland SE, one of the largest dairy companies in Germany, Tnuva, the largest dairy conglomerate in Israel, and Tempo. In November 2021, the multinational venture capital fund, Hanaco Ventures, led a funding round for the company and raised $120 million to increase the company's manufacturing capabilities. In April 2022, the company announced that it is planning to open the world's largest fermentation facility in Denmark. The full-scale fermentation facility will be built on more than 750,000 square feet in the Kalundborg Eco-industrial Park. In June 2022, Remilk received FDA approval, and in early 2023 the Singapore Food Agency and later the Ministry of Health in Israel granted the company regulatory approval to market and sell cow-free milk products to consumers.